These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6786356)

  • 1. Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction.
    Harris RB; Newman J; Johnson AJ
    Biochim Biophys Acta; 1981 May; 668(3):456-70. PubMed ID: 6786356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. II. Further purification with thiol-disulfide interchange chromatography and additional evidence for disulfide bonds susceptible to limited reduction.
    Harris RB; Johnson AJ; Hodgins LT
    Biochim Biophys Acta; 1981 May; 668(3):471-80. PubMed ID: 6786357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
    Counts RB; Paskell SL; Elgee SK
    J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and properties of bovine factor VIII (antihemophilic factor).
    Vehar GA; Davie EW
    Biochemistry; 1980 Feb; 19(3):401-10. PubMed ID: 7356933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of the factor VIII complex.
    Thorell L; Blombäck B
    Thromb Res; 1984 Aug; 35(4):431-50. PubMed ID: 6435279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.
    Griggs TR; Cooper HA; Webster WP; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2814-8. PubMed ID: 4542779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD; Kass L; Lang PD
    J Clin Invest; 1969 May; 48(5):957-62. PubMed ID: 5780204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of different activated forms of factor VIII, the human antihemophilic A factor.
    Bihoreau N; Sauger A; Yon JM; Van de Pol H
    Eur J Biochem; 1989 Oct; 185(1):111-8. PubMed ID: 2509202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced yield of antihemophilic factor and von Willebrand factor by cryoprecipitation with polyethylene glycol.
    Johnson AJ; Macdonald VE; Brind J
    Vox Sang; 1979; 36(2):72-6. PubMed ID: 313629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of porcine and human ristocetin-Willebrand factor.
    Olson JD; Brockway WJ; Fass DN; Bowie EJ; Mann KG
    J Lab Clin Med; 1977 Jun; 89(6):1278-94. PubMed ID: 405441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on factor VIII-related protein. I. Ultrastructural and electrophoretic heterogeneity of human factor VIII-related protein.
    Beck EA; Tranqui-Pouit L; Chapel A; Perret BA; Furlan M; Hudry-Clergeon G; Suscillon M
    Biochim Biophys Acta; 1979 May; 578(1):155-63. PubMed ID: 313218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF).
    Nilsson IM
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):33-7. PubMed ID: 3133776
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isolation and some properties of factor VIII (antihemophilic factor)].
    Bykowska K; Lopaciuk S; Michalski R
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):283-92. PubMed ID: 998139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver staining of high molecular weight proteins on large-pore polyacrylamide gels.
    Perret BA; Felix R; Furlan M; Beck EA
    Anal Biochem; 1983 May; 131(1):46-50. PubMed ID: 6193732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular structural studies of human factor VIII.
    McKee PA; Andersen JC; Switzer ME
    Ann N Y Acad Sci; 1975 Jan; 240():8-33. PubMed ID: 122889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.